Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer

The possible treatments options for metastatic hormone-sensitive prostate cancer (mHSPC) have dramatically increased during the last years. The old backbone, which androgen-deprivation therapy (ADT) is the exclusive approach for hormone-naïve patients, has been disrupted. Despite the fact that sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattrini, Carlo, Castro, Elena, Lozano, Rebeca, Zanardi, Elisa, Rubagotti, Alessandra, Boccardo, Francesco, Olmos, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770296/
https://www.ncbi.nlm.nih.gov/pubmed/31547436
http://dx.doi.org/10.3390/cancers11091355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770296/
https://www.ncbi.nlm.nih.gov/pubmed/31547436
http://dx.doi.org/10.3390/cancers11091355

Ejemplares similares